3,690
edits
TYK13: Difference between revisions
Jump to navigation
Jump to search
no edit summary
m (1 revision imported) |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
All of the following medications are known to ENHANCE neuromuscular blockade EXCEPT: | All of the following medications are known to ENHANCE neuromuscular blockade EXCEPT: | ||
| Line 13: | Line 12: | ||
E. Phenytoin | E. Phenytoin | ||
<div class="mw-customtoggle-TYK_Answer" style="text-align: right; color:#0000ff">Click for Answer</div> | |||
<div class="mw-collapsible- | <div class="mw-collapsible mw-collapsed" id="mw-customcollapsible-TYK_Answer"> | ||
==Answer== | ==Answer== | ||
The answer is E. All of the following enhance blockade except Phenytoin. Phenytoin and carabamazepine ANTAGONIZE the blockade by increasing the clearance of NMBDs through up regulation of hepatic metabolism. Volatile agents enhance blockade in a dose dependent manner (just ask Yaster), although how this occurs is not known. Local anesthetics, given in low doses, augment the blockade by inhibiting propagation along the nerve, an inhibiting release of acetylcholine (ACh) into the synaptic cleft. Aminoglycosides augment blockade with aminosteroid, but not benzylisoquiolinium neuromuscular blocking drugs (NMBD). Furosemide, in low doses (1mg/kg) augments the blockade by inhibiting cAMP production, leading to decreased ACh output. Note the hypokalemia (from diuretics) hyperpolarizes the membranes, requiring more ACh-receptor binding to stimulate membrane depolarization; hence, less NMBD is required for blockade (e.g. enhanced blockade). | The answer is E. All of the following enhance blockade except Phenytoin. Phenytoin and carabamazepine ANTAGONIZE the blockade by increasing the clearance of NMBDs through up regulation of hepatic metabolism. Volatile agents enhance blockade in a dose dependent manner (just ask Yaster), although how this occurs is not known. Local anesthetics, given in low doses, augment the blockade by inhibiting propagation along the nerve, an inhibiting release of acetylcholine (ACh) into the synaptic cleft. Aminoglycosides augment blockade with aminosteroid, but not benzylisoquiolinium neuromuscular blocking drugs (NMBD). Furosemide, in low doses (1mg/kg) augments the blockade by inhibiting cAMP production, leading to decreased ACh output. Note the hypokalemia (from diuretics) hyperpolarizes the membranes, requiring more ACh-receptor binding to stimulate membrane depolarization; hence, less NMBD is required for blockade (e.g. enhanced blockade). | ||
==Notes== | ==Notes== | ||
<references /> | <references /> | ||
[http://web.squ.edu.om/med-Lib/MED_CD/E_CDs/anesthesia/site/content/v02/020433r00.HTM Pharmacology of Muscle Relaxants and Their Antagonists] | [http://web.squ.edu.om/med-Lib/MED_CD/E_CDs/anesthesia/site/content/v02/020433r00.HTM Pharmacology of Muscle Relaxants and Their Antagonists] | ||
==Keywords== | ==Keywords== | ||
</div> | </div> | ||
---- | ---- | ||
---- | ---- | ||
<p style="text-align: center;">[[TYK12|<Prev Question]] --- [[TYK14|Next Question>]]</p> | <p style="text-align: center;">[[TYK12|<Prev Question]] --- [[TYK14|Next Question>]]</p> | ||
<p style="text-align: center;">[[TYK About | About Test Your Knowledge]]</p> | <p style="text-align: center;">[[TYK About | About Test Your Knowledge]]</p> | ||